Intraperitoneal radioactive phosphate in early ovarian carcinoma: an analysis of complications.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 2022522.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Intraperitoneal radioactive chromic phosphate was administered to 69 patients with Stage I and II ovarian carcinoma who had undergone comprehensive surgical staging. Intestinal obstruction requiring surgical intervention occurred in four patients and was the most severe complication. Abdominal pain was the most common post-therapy complaint. Attention to time and technique of drug administration could minimize complications.
Medical subject headings
- Chromium Compounds
- Ovarian Neoplasms
- Phosphorus Radioisotopes
- Radiotherapy